Reaction of
[Zr6Cl18H5]3-
(1) with 1 equiv of TiCl4 yields a new cluster
anion,
[Zr6Cl18H5]2-
(2), which can be
converted back into
[Zr6Cl18H5]3-
(1) upon addition of 1 equiv of Na/Hg. Cluster
2 is paramagnetic and unstable
in the presence of donor molecules. It undergoes a
disproportionation reaction to form 1, some Zr(IV)
compounds,
and H2. It also reacts with TiCl4 to form
[Zr2Cl9]- (4)
and a tetranuclear mixed-metal species,
[Zr2Ti2Cl16]2-
(3).
The oxidation reaction of 1 with TiCl4 is
unique. Oxidation of 1 with H+ in
CH2Cl2 solution results in
the
formation of [ZrCl6]2-
(5) and H2, while in py solution the oxidation
product is [ZrCl5(py)]-
(6). There is no
reaction between 1 and TiI4, ZrCl4,
[TiCl6]2-,
[ZrCl6]2-, or
CrCl3. Compounds
[Ph4P]2[Zr6Cl18H5]
(2a),
[Ph4P]2[Zr2Ti2Cl16] (3a),
[Ph4P]2[Zr2Cl9]
(4a),
[Ph4P]2[ZrCl6]·4MeCN
(5a·4MeCN), and
[Ph4P][ZrCl5(py)] (6a)
were
characterized by X-ray crystallography. Compound 2a
crystallized in the trigonal space group R3̄ with
cell
dimensions (20 °C) of a = 28.546(3) Å,
b = 28.546(3) Å, c = 27.679(2) Å,
V = 19533(3) Å3, and Z =
12.
Compound 3a crystallized in the triclinic space group
P1̄ with cell dimensions (−60 °C) of a
= 11.375(3) Å, b
= 13.357(3) Å, c = 11.336(3) Å, α =
106.07(1)°, β = 114.77(1)°, γ = 88.50(1)°,
V = 1494.8(7) Å3, and Z
=
1. Compound 4a crystallized in the triclinic space
group P1̄ with cell dimensions (−60 °C) of
a = 12.380(5) Å,
b = 12.883(5) Å, c = 11.000(4) Å,
α = 110.39(7)°, β = 98.29(7)°, γ =
73.12(4)°, V = 1572(1) Å3, and
Z = 2.
Compound 5a·4MeCN crystallized in the monoclinic
space group P21/c with cell
dimensions (−60 °C) of a =
9.595(1) Å, b = 19.566(3) Å, c =
15.049(1) Å, β = 98.50(1)°, V =
2794.2(6) Å3, and Z = 2. Compound
6a
crystallized in the monoclinic space group
P21/c with cell dimensions (20 °C)
of a = 10.3390(7) Å, b =
16.491(2)
Å, c = 17.654(2) Å, β = 91.542(6)°,
V = 3026.4(5) Å3, and Z =
4